White Papers and Resources
Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
Webcast: Biosimilars: Friend or Foe to Healthcare?
March 31, 2015 | White Papers and Resources |
Understanding the opportunities for biosimilars and the threats to innovator biologics
Brought to you by Inizio
Webinar: Understanding the patient journey in China
March 31, 2015 | White Papers and Resources |
The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on …
Brought to you by Inizio
Webinar: Capturing “in-the-moment” patient and physician insights
March 27, 2015 | White Papers and Resources |
Utilising the benefits of mobile technology
Brought to you by Inizio
Webinar: Observational Research
March 27, 2015 | White Papers and Resources |
Presenting a window on the world of your customer
Brought to you by Inizio
Webinar: The Brazil Conundrum
March 27, 2015 | White Papers and Resources |
Conducting research in one of the world’s largest pharma markets
Brought to you by Inizio
Webinar: Demand calibration: What’s inside the black box?
March 27, 2015 | White Papers and Resources |
The process of demand calibration of preference share (down-weighting) is often a proprietary “black box” technique, which can mean that the client is unsure how …
Brought to you by Inizio
Free Thinking: Behavioural economics
March 27, 2015 | White Papers and Resources |
Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Brought to you by Inizio
Article: The Colombia Conundrum
March 27, 2015 | White Papers and Resources |
Published in eye for pharma 30 January by Marc Yates
Brought to you by Inizio
Ageing in China: The Implications for Healthcare
March 27, 2015 | White Papers and Resources |
Published in eye for pharma 12 December by Marc Yates
Brought to you by Inizio
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?
March 27, 2015 | White Papers and Resources |
Published in Eye for Pharma 10 November by Marc Yates
Brought to you by Inizio